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Abstract
Implanted cardiac defibrillators (ICDs) seek to automatically detect and terminate potentially
lethal ventricular arrhythmias by applying strong internal electric shocks across the heart. However,
the optimisation of the specific electrode design and configurations represents an intensive area of
research in the pursuit of reduced shock strengths and fewer device complications and risks. Compu-
tational whole-torso simulations play an important role in this endeavour, although knowing which
specific metric should be used to assess configuration efficacy and assessing the impact of different pa-
tient anatomies and pathologies, and the corresponding effect this may have on different metrics has
not been investigated. We constructed a cohort of CT-derived high-resolution whole torso-cardiac
computational models, including variants of cardiomyopathies and patients with differing torso di-
mensions. Simulations of electric shock application between electrode configurations corresponding
to transveneous (TV-ICD) and subcutaneous (S-ICD) ICDs were modelled and conventional met-
rics such as defibrillation threshold (DFT) and impedance computed. In addition, we computed a
novel metric termed the shock vector efficiency (η), which quantifies the fraction of electrical energy
dissipated in the heart relative to the rest of the torso. Across the cohort, S-ICD configurations
showed higher DFTs and impedances than TV-ICDs, as expected, although little consistent differ-
ence was seen between healthy and cardiomyopathy variants. η was consistently < 2% for S-ICD
configurations, becoming as high as 13% for TV-ICD setups. Simulations also suggested that a total
torso height of approximately 20 cm is required for convergence in η. Overall, η was seen to be
approximately negatively correlated with both DFT and impedance. However, important scenarios
were identified in which certain values of DFT (or impedance) were associated with a range of η
values, and vice-versa, highlighting the heterogeneity introduced by the different torsos and patholo-
gies modelled. In conclusion, the shock vector efficiency represents a useful additional metric to
be considered alongside DFT and impedance in the optimisation of ICD electrode configurations,
particularly in the context of differing torso anatomies and cardiac pathologies, which can induce
significant heterogeneity in conventional metrics of ICD efficacy.
2
1 Introduction
Defibrillation, via the application of a strong electric field across the heart, remains the only effec-
tive treatment for a host of otherwise life-threatening cardiac arrhythmias. Implantable cardioverter-
defibrillators (ICDs) are capable of both sensing the occurrence of these lethal arrhythmias and auto-
matically delivering the appropriate electrotherapy [5, 29, 18]. Standard (transvenous) ICD (TV-ICD)
configurations are intra-cardiac devices, which apply strong biphasic shocks between a shocking lead
(coil) placed in the right ventricular (RV) cavity and the return can (the battery generator housing)
placed under the pectoral muscle. As they are directly in contact with the heart, these TV-ICDs can
also perform anti-tachycardia pacing from the RV electrode [28]. In some patient groups, however, such
an intra-cardiac approach is often not appropriate (or required). In these patients, the use of subcuta-
neous ICDs (S-ICDs) has become increasingly popular, driven by the relative ease of implantation and
reduced complications (lead extractions) compared to TV-ICDs [1]. In such devices, configurations usu-
ally consist of a shocking coil placed subcutaneously, to the left of the sternum, with the return can placed
at the mid-axillary line, level with the heart. S-ICDs, however, typically required approximately 5 times
greater shock energy to defibrillate, compared to TV-ICDs, due to the extra-cardiac lead placement.
Despite their success in terminating arrhythmic events, ICDs are far from an optimal therapy. ICDs
deposit the majority of their energy in non-cardiac tissues, meaning that strong shock-strengths are
required to successfully defibrillate, limiting ICD battery life and resulting in cardiac (and non-cardiac)
tissue damage and impaired mechanical function [14, 23]. The relatively high incidence of inappropriate
shocks (approximately 10% per annum) [6] also causes significant pain and psychological issues for ICD
recipients [25]. There is thus an increasing drive to develop novel ICD electrotherapy protocols and
electrode configurations that can more effectively terminate lethal arrhythmias with reduced peak shock
strengths and overall shock energies.
The Defibrillation Threshold (DFT) is the conventional clinical metric used to define the energy or
voltage required to defibrillate a patient using a particular electrotherapy. A series of basic science and
theoretical studies have linked DFT with the shock strength required to raise 95% of myocardial tissue
to an extracellular potential gradient of > 5 V/cm [33, 32]. This concept is related to the critical mass
hypothesis, that suggests that fibrillatory activity can only be sustained by a certain ’critical mass’ of
myocardium into which it can propagate. This DFT surrogate is convenient for use in computational
modelling bidomain studies, which intrinsically obtain extracellular potential fields throughout the 3D
volume of the myocardium [13, 7, 16, 17, 24]. However, of crucial importance in its use in assessing ICD
efficacy is that it provides no information regarding how much energy is wasted in extra-cardiac tissue
for a given configuration.
In this study, we present a novel metric, termed the shock vector efficiency, which computes the relative
shock energy dissipated in the ventricular myocardium, compared to the rest of the torso. We evaluate
this metric by constructing a cohort of CT-derived high resolution whole torso-cardiac models, the
pipeline for construction of which is described in full detail, including variants of cardiomyopathies (CM)
such as dilated (DCM) and hypertrophic (HCM) and patients of different physical torso dimensions. By
performing realistic bidomain simulations of shock application through ICD electrodes, we demonstrate
the potential of our metric at discriminating optimal shock configurations which have similar DFTs and
current pathway impedances, and its utility as an additional method of quantifying defibrillation efficacy
in the latest novel variants of ICD setups.
2 Methods & Materials
2.1 Model Creation
2.1.1 Patient Selection
Anonymised contrast CT scan datasets were obtained with the Siemens Somatom Definition Flash Dual
Source CT, with a resolution of 0.54 × 0.54 × 1mm. Additional higher resolution cardiac scans (0.28 ×
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Classification
Patient details Torso details
Gender Age Height Weight BMI Width Depth Heightyears cm kg kg * m-2 cm cm cm
Large Male 59 177 101 32.2 (Obese) 42.0 31.0 37.5
Medium Male 43 178 90 28.4 (Overweight) 36.9 27.5 30.5
Small Female 57 173 60 20.0 (Healthy) 28.7 20.0 27.5
TAVI 1 Female - - - - 38.3 27.1 42.1
TAVI 2 Male 85 180 85 26.2 (Overweight) 36.1 28.6 35.7
Table 1: Patient and torso details of the scans used for models. Torso depth and width are measured in a
transverse plane at the level of the xiphoid process.
whole torso  
CT scan
high-res  
cardiac CT scan
tissue/organ  
segmentation
cardiac  
segmentation
smoothing & 
combining
Figure 1: Outline of the pipeline used to generate a complete segmentation from patient-specific CT scans.
0.28 × 0.8mm were also available for these patients. From these available scans, 3 otherwise healthy
patient scans were initially chosen, who were imaged to investigate symptoms of chest pain. These initial
datasets were selected based on: (1) torso size; (2) presence of soft tissue scan and a heart scan with
good contrast; and (3) thoracic organs with healthy anatomy. Torso size was an important consideration
due to the fact that defibrillation efficacy varies with body mass index (BMI) [9]; torsos were classified as
‘Large’, ‘Medium’ and ‘Small’ (Table 1). In addition to these 3 healthy patients, 2 further patient scans
were obtained from transaortic valve implantation (TAVI) recipients, of resolution 0.64 × 0.64 × 1mm.
Such patients had the advantage of wide field-of-view torso high resolution CT scans, along with high
resolution separate cardiac scans (0.35× 0.35× 0.6mm). The 2 patients selected had no specific cardiac
abnormalities. Note here that the two TAVI patients included in the cohort had torso dimensions
somewhere between the Medium and Large healthy patients. All patients consented for the use of their
data in ethically approved research: UK Research Ethics Committee reference number 19/HRA/0502 &
15/LO/1803.
2.1.2 Image Processing & Analysis
The image processing and analysis pipeline is shown schematically in Fig. 1. Seg3D (www.sci.utah.edu/)
was used to segment the CT scans of the three patients into regions of interest, based on the major organs
and tissues in the torso; these included (where identifiable) the skin, skeletal muscles, fat, bones, lungs,
spleen, liver, stomach, kidneys and spinal cord. The heart was segmented into separate chambers,
blood pools and great vessels using the Siemens Axseg v4.11 [31] automated segmentation tool along
with the higher resolution cardiac CT scans to produce smooth image segmentations, with endocardial
trabeculations and papillary muscles not included. The heart segmentation was then combined with
the other regions of interest in a combined segmentation of the whole torso. The CT scans for the 3
healthy patients did not encompass the entire desired extent of the torso; thus, corresponding patient
MR data for the same patients was registered to the CT data and used to facilitate whole-torso model
construction, allowing full representation of lungs, rib-cage and skin above and below the heart. This
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LVEDD Ventricular Wall Thickness
mm cm
Healthy DCM Healthy HCM
Large 54.7 73.4 1.0 1.9
Medium 39.8 65.0 1.0 1.7
Small 40.0 55.6 0.9 1.7
Table 2: Dimensions of the hearts used, measured in a transverse plane approximately midway up the heart,
through the LV.
was not necessary for the 2 TAVI patients.
The hearts of the 3 healthy patients were then post-processed to reproduce hypertrophic cardiomyopathy
(HCM, specifically, symmetrical, as in [12]) and dilated cardiomyopathy (DCM) model variants within the
same overall torso geometry. HCM was modelled by dilating the left ventricular (LV) wall homogeneously
to encroach on the LV blood-pool; DCM was modelled by dilation of the LV wall in the direction
perpendicular to the heart’s long axis, resulting in radial dilation but little dilation in the apico-basal
direction. The left ventricle end diastolic diameters (LVEDD) of the original and DCM hearts, and the
ventricular wall thicknesses of the original and HCM hearts, are given in Table 2; the dimensions match
the values expected for healthy hearts, as well as hearts affected by HCM and DCM [19].
2.1.3 Finite Element Mesh Generation
Final combined segmentations were converted to a tetrahedral mesh using the Tarantula meshing soft-
ware [21]. Segmentation tags corresponding to each organ were mapped over to individual elements
as numerical tags, allowing specific functional properties to be assigned on a per region basis. In this
conversion, higher resolution was used for the components of the mesh corresponding to the ventricles as
the region of interest, while other regions were less refined to ensure computational tractability. Mean
nodal spacing within the ventricles was approximately 600 µm, with each full torso model containing ap-
proximately 75− 100 million elements. Meshes were additionally smoothed on all regions using the open
source software Meshtool (https://bitbucket.org/aneic/meshtool/src) due to sharp edges which
may cause artefacts upon the application of strong electric fields [4]. Figure 2A shows example images of
the 5 initial whole torso models, with a transverse clipping plane used through the midline of the heart
to expose the internal details. Figure 2B shows a full torso view of the TAVI 2 patient, where the skin,
fat and muscles have been rendered transparent to allow visualisation of the other internal organs. In
Figure 3, example images of the three different conditions of heart are shown for one patient, highlighting
the ventricular dilation (DCM) and wall thickening (HCM) imposed within the healthy models.
2.1.4 Cardiac Fibre Representation
Anisotropic conduction due to the myofibre architecture within ventricular myocardium is known to have
important implications in the response of the tissue to strong external electric fields. In contrast to earlier
whole-torso cardiac models [16, 17, 12], we explicitly included an anatomically-realistic representation of
cardiac fibre orientation within the ventricular tissue using a previously validated approach, as described
in [2], described briefly below.
Based on the interface between the segmented components of the heart, the base, epicardium and endo-
cardium were defined, and the point apex specified manually. A smoothly varying field was then defined
between the apex and the base by solving Laplace’s equations with Dirichlet boundary conditions at
these surfaces, and similarly for the epi- and endocardium; the gradient of these fields determines the
apicobasal and transmural directions. These two directions were used to define a local coordinate system
for each point in the mesh. For each point, a rotation angle α was calculated according to
α(d) = αendo(1− d) + αepid, (1)
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3 shows views from Meshalyzer of the 3 healthy / extended torso models (left) along with the 2
’new’ full torso models (right).
Figure 3: Finite element meshes of Small (top), Medium (middle), Large (bottom), New1 (top
right) and New2 (bottom right).
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A B
Small Medium Large
TAVI 1 TAVI 2
Figure 2: Illustrating images of 5 different meshes constituting the initial cohort. (A) Cuts through the torso,
approximately along the centre line through the heart, highlighting the internal organs and tissues in each model.
Images are approximately to scale, demonstrating the differences in physical geometry between patients. (B) Image
of an example whole torso mesh, shown in a solid mesh format with outer skin, muscles and fat removed to allow
highlighting of the lungs (blue), liver (dark green), kidneys (light green), bones (yellow), ventricles (red) and blood
vessels (orange).
He
al
th
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M
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M
Figure 3: Illustrating images of the three cardiomyopathy variants modelled. Top: Healthy; Middle: HCM;
Bottom: DCM. Each row shows the entire ventricles with a clipping plane used to expose endocardial surfaces
(left); right images show slices taken along the same clipping plane. Blue slices correspond to the healthy case for
reference.
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Organ Conductivity (S/m)
Blood 0.6667
Fat 0.0500
Kidney 0.1667
Liver 0.1667
Lungs 0.0714
Muscle (skeletal) 0.4444
Skin 0.0500
Spinal Cord 0.1000
Spleen 0.1000
Stomach 0.1000
Table 3: Organ conductivity values.
where d is the transmural depth (normalised from 0 to 1), αendo is the rotation angle on the endocardial
surface, and αepi is the rotation angle on the epicardial surface. The literature gives αepi = −60deg
and αendo = 60 as acceptable values [26]. The rotation angle varies smoothly between the endo- and
epicardium and defines the fibre direction.
2.2 Model Simulation
2.2.1 Tissue Conductivities
Save for the heart, all other organs were assumed to be a homogeneous resistor with negligible capac-
itance [12]. Conductivity values were as in [12], with spinal cord conductivity from [10] and spleen
conductivity from [8]. The conductivity values used are summarised in Table 3. Conductivities of ven-
tricular myocardium were assigned values from the literature as 0.24, 0.035 S/m in the intracellular
fibre/cross-fibre directions and 0.24, 0.2 S/m in the extracellular fibre/cross-fibre directions [15].
2.2.2 Cardiac Tissue Representation
In the general simulation framework, the ventricular myocardial tissue was represented by the bidomain
model of cardiac electrophysiology, recast in elliptic-parabolic form [3]
−∇ · (σi + σe)∇φe = ∇ · σi∇Vm,
−∇ · σb∇φe = Ieb,
βCm
∂Vm
∂t
= ∇ · σi∇φi − βIion(Vm,ν)
(2)
where φi and φe are the intra and extra-cellular potentials, φb is the potential of the bath (representing
the surrounding non-myocardial tissues), Vm = φi − φe is the transmembrane potential, σi and σe are
the intra and extra-cellular conductivity tensors, β = 1400 cm−1 is the membrane surface area to volume
ratio, Im is the transmembrane current density, Cm = 1 µF/cm2 is the membrane capacitance per unit
area and Iion is the membrane ionic current density, as a function of the transmembrane potential Vm
and the vector of state variables ν. At ventricular myocardium boundaries, no flux boundary conditions
are imposed for φi, with φe being continuous. At the boundaries of the conductive bath surrounding
the tissue (in this case, the extremities of the torso i.e. the skin), no flux boundary conditions for φe
are imposed. Due to the nature of this specific setup, no extracellular stimuli applied to the interstitial
space is present, and nor is any transmembrane stimulus. The only stimulus represented, therefore, is
the extracellular stimulus applied to the bath, Ieb, defined between the ICD-electrodes. Note that all
non-cardiac tissues are defined here as ‘bath’.
For simulations of DFT (using the empirical metric ‖∇φe‖ > 5 V/cm in more than 95% of tissue), two
setups were used for the ventricular myocardium. In the first, the tissue was assumed to behave passively,
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wherein the transmembrane ionic current was represented by
Iion =
Vm
Rm
, (3)
where Rm is the membrane resistance with a standard value of 9 kΩ/cm2 and V restm = −80 mV. Note that
values of Rm, V restm and β vary and those chosen are within the range of experimentally obtained values
commonly used in computational cardiac modelling [20]. This first full bidomain setup was also used
to compute the total impedance of the tissue which required injection (or withdrawal) of extracellular
current, Ieb, at the ICD electrodes. The second representation solved the Laplace problem, where the
capacitive effects of the ventricular myocardium are ignored and the ventricular myocardium behaves as
a simple (yet still anisotropic) conductor; in this case, Equations 2 simplify to
∇ · (σi + σe)∇φe = 0,
∇ · σb∇φe = 0,
(4)
where the top equation is solved in the (anistropic) ventricular myocardium and the lower equation in
all other non-ventricular (isotroptic) tissues and organs which were treated as extracellular conductors
(the bath). Appropriate boundary conditions are applied to nodes representing the electrodes defining
the ICD setups being 1 for positive (shocking) coils and 0 for negative ground electrodes.
2.2.3 ICD Electrode Modelling
TV-ICD and S-ICD setups were modelled. Two variants of TV-ICD configurations were represented,
including a 5 cm long shocking electrode inside the right ventricle (RV) (TV-ICD1) with a sub-clavicle
can, with a further representation including an additional 8 cm long ground electrode in the Superior Vena
Cava (SVC) (TV-ICD2). In the latter case, two shock vectors are simultaneously used, one between the
RV coil and can, and the other between the RV coil and SVC coil. For the standard S-ICD representation,
the subcutaneous shocking electrodes were defined as cylinders of 8 cm in length and 3 mm diameter.
The can was defined as a cylinder of 7 cm diameter and 2 cm thickness, placed at the mid-axillary
line at the level of the 6 th and 7 th ribs, within muscle and fat tissues with approximate respective
mesh discretisations of 1.1 mm and 0.6 mm, respectively, thus faithfully resolving the can morphology.
It is noted, however, that more recent devices may be of slightly slimmer design. During simulations,
boundary conditions were specified on all finite element nodes within the geometrical regions defined by
the electrodes above. For shocking electrodes, extracellular potential was fixed at the specified values to
define the strength of the applied shock; for ground electrodes, extracellular potential was defined to be
0 mV throughout.
2.2.4 Simulation Protocols
When using the full bidomain representation of cardiac tissue, monophasic shocks were applied by de-
livering a constant voltage across shocking electrodes for a duration of 30 ms. As the time constant
of the membrane is approximately 5 ms, delivering a 30 ms shock ensured approximate steady-state of
the system had been reached. In the case of using a simple Laplace solve, a single static solution was
obtained due to its temporal independence.
For each electrode configuration, the impedance (resistance) of the pathway between the electrodes was
also computed. To this end, simulations of a constant current injection between shocking and ground
electrodes were performed with membrane dynamics set to be passive.
2.3 Data Analysis
2.3.1 DFT Computation
Extracellular potentials throughout the ventricular myocardium at shock-end were used to evaluate DFT.
Specifically, in accordance with previous experimental [33, 32] and simulation [13, 7, 16, 17, 24] studies,
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the voltage level at which 95% of the ventricular myocardium had ‖∇φe‖ > 5 V/cm was defined as the
DFT. A defined voltage of 50 V was applied to all models, and then linearly scaled to define the DFT
at which the above criteria were met. A test to check for linearity was performed whereby the applied
voltage was increased by a factor of two and the DFT re-computed.
Different possible methods exist to compute the energy delivered by the capacitor. We chose to compute
the stored energy in terms of the capacitance by Energy = CV
2
2 , in-line with previous simulation studies
[16], where C = 100 µF and V is the required voltage DFT for the particular electrode configuration.
2.3.2 Impedance Computation
To compute impedances (resistances), simulations of total current injection were used and average po-
tentials were extracted over the surface of the shocking electrodes to compute voltage-drops between the
shocking electrode and the ground electrode. The specific resistances of the electrode configurations was
then derived via Ohm’s Law, R = V/I.
2.3.3 Shock Vector Efficiency
In addition to quantifying the efficacy of a particular electrode setup in terms of the DFT (as a voltage
or equivalent stored energy), we also introduce here the quantification of a metric which we term the
shock vector efficiency. The shock vector efficiency (η) represents the ratio of the electrical energy which
is dissipated (via Joule heating) within the ventricular myocardium, relative to the total electrical energy
dissipated within all other tissues and organs within the torso (including the myocardium).
If the power dissipated (P ) per unit volume (τ) is
P = J ·E (5)
where J is the current density and E the electric field within the tissue and J = σE, where σ is the
tissue-specific electrical conductivity. For all of the non-ventricular myocardial tissues and organs within
the torso, the tissue is assumed to be isotropically-conducting, meaning that the conductivity tensor σ
becomes a scalar and J and E are in the same direction. For ventricular myocardial tissue, conductivity
is defined to be anisotropic, and thus the full tensor form of σ must be used, constructed from the fibre
orientation data defined in Section 2.1.4.
As electrical power and energy are equivalent here for a fixed duration shock, we thus define the shock
vector efficiency to be
η =
∫
τmyo
J ·Edτ∫
τtotal
J ·Edτ , (6)
where τtotal = τmyo + τnon−myo. η thus gives a representation of the fraction of the shock’s energy that
is actually delivered to the ventricles, relative to that delivered to the whole torso.
It is noted here that we applied fixed strength shocks, not biphasic shocks with exponentially decaying
tilts. However, as all impedances are represented as Ohmic, as voltage changes with time, the same
fraction of voltage is dropped across the heart, relative to the rest of the torso. Thus, ignoring capacitive
effects and treating the torso and heart as a simple Ohmic resistor, the shock vector efficiency would
remain constant throughout the biphasic shock. We do not, however, explicitly compute the total energy
delivered by the device. Consequently, the metric is only a comparison of relative energies between
the myocardial and whole torso domains; it does not represent the explicit computation of the energy
dissipated by the device as we do not simulate the full nature of a biphasic stimulus pulse, as noted.
2.4 Comparison of Simulation Methods
Full bidomain solutions (considering the capacitive properties of the heart, solving the full equations as
stated in Section 2.2.2 with a passive cell model) in addition to simple Laplace solutions (solving only
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3 Results
3.1 Defibrillation Threshold
Figure 8 shows the distribution of extracellular potential throughout the torso model for the di↵erent
electrode configurations, within the ’New1’ torso model.
Figure 8: Distribution of  e throughout the ’New1’ torso model for the di↵erent electrode config-
urations.
Figure 9 summarises the DFTs, both in terms of voltage and stored energy. Note that this
table includes cardiomyopathy cases, as well, for the standard small/medium/large cases. Figure
10 also plots the variation in voltage DFT with respect to di↵erent electrode placements for each
model (only considering healthy cases).
3.2 Relation of DFTs with Shock Impedance
For each electrode setup, electrical impedance was computed between anode and cathode elec-
trodes. Figure 11 details all impedance values for all models in the cohort, for all electrode
placements.
To understand how the computed impedance relates to the DFT for each electrode placement,
a correlation plot was then produced between impedance and (energy) DFT, shown in Figure 12.
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S-ICD TV-ICD1 TV-ICD2
Figure 4: Distribution of φe throughout the torso volume for each different electrode configuration for a stimulus
of 50 V. Each panel shows frontal views (left) as well as views with a clipping plane exposing the intra-torso cavity
along the mid-line (right). Example torso corresponds to TAVI 1 model.
the middle equation in Section 2.2.2) were co puted initially for all healthy torso models in the cohort.
Differences in computed DFTs were seen to be consistently less than 2% using th φe solutions tak
at shock-end in the bidomain solves (mean values of initial cohort of 5 patients) in comparison to the
Laplace solutions. Thus, throughout the rest of the study, simple Laplace solves were performed for φe
simulation and obtaining DFTs. Ful b domain simulations were performed for impedance calculations,
as described in S ction 2.2.2.
3 Results
3.1 Defibrillation Threshold
Figure 4 compares the distribution of φe throughout the torso volume for the subcutaneous and two
tranveneous electrode setups. A number of important features are demonstrated in this figure; firstly,
the distribution of φe throughout the whole torso is very different for each configuration; and, secondly,
that the rate of decay (i.e. the gradient) of the potential is also very different throughout the heart.
Quantification of the DFT accounts for these differences in the gradient of φe throughout the heart.
Figure 5A presents the energy DFT for all torsos, comparing different electrode configurations. Here, it
is clear that the different electrode configurations result in substantially different DFTs for each torso,
along with the expected difference in DFT for different configurations within a single torso. Specifically,
the values for the S-ICD configuration are substantially higher (generally, over 5 times higher) than the
transvenous configurations, which are generally < 10 J, as expected. Also, as expected [27], DFTs of
single coil devices are slightly higher than dual-coil devices.
3.2 Electrical Impeda ce
The specific DFT within each model is sensitive to the volts ‘dropped’ across the heart, which is governed
by the organ anatomy and their respective conductivities. Measurement of impedance (resistance) in
this case can provide a useful indication of the reasons for differing DFTs between models, in relation to
different specific current pathways. For each electrode setup, electrical impedance was computed between
anode and cathode electrodes. Figure 5B details all impedance values for all models in the cohort, for
all electrode placements.
In general, the smaller torsos have lower impedances for all electrode configurations, compared to the
larger torsos, as expected due to the closer physical proximity of electrodes in these cases. All transvenous
configurations also result in substantially lower impedances across the cohort; again expected due to the
shorter current paths and the less high-resistance tissue (e.g. bones, fat) the current must transverse
between electrodes.
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Figure 5: DFTs (panel A, in energy), electrical impedance (panel B), and shock vector efficiency (panel C) shown
for each patient in the cohort, comparing different electrode configurations (coloured bars).
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3.3 Shock Vector Efficiency
Figure 5C shows the shock vector efficiency computed from φe for each patient in the initial cohort for all
electrode configurations. Immediately, a significant difference between S-ICD and TV-ICD configurations
is evident, with η for TV-ICD configurations typically being 5 times greater than η for the S-ICD
configuration. There is also a consistently higher η for the TV-ICD 2 configuration (including the extra
SVC electrode), relative to the TV-ICD 1 configuration. The Small torso also has a noticeably larger
η value across the configurations compared to other patients. However, the Large torso has a higher η
than the Medium torso, indicating that η does not necessarily scale with torso size.
3.4 Convergence of η with Torso Dimensions
As seen in Equation 6, the computation of η explicitly depends upon the volume of torso included in the
calculation. Thus, we assessed how the computed value of η depends on the size of the torso modelled;
only the S-ICD setup was considered as the TV-ICD required larger torso sizes due to their higher
electrode placements. This was done in two separate ways: firstly, the simulation of an applied shock
was performed on a full size torso model (the TAVI 2 model), but only progressively larger regions of
torso either side of the heart were included in the post-simulation analysis (in Equation 6); secondly,
torsos of differing dimensions (including progressively larger regions of torso either side of the heart)
were used in the initial simulation of the applied shock (and for subsequent analysis).
Figure 6B plots the value of η as a function of the half-torso height included in the torso model as the
half-height increases from 80 to 160 mm (shown schematically in Figure 6A), along with the DFT for
comparison in Figure 6C. Whilst the DFT increases as the size of the torso modelled increases, the shock
vector efficiency decreases, although to a lesser degree. The magnitudes of these changes are important
to note: DFT increases by over 60% whilst η decreases by approximately 30%. Figure 6D also plots the
total energy dissipated within the heart and within the torso separately. The energy dissipated within
the heart monotonically decreases with torso size (by approximately 25%), whereas the energy dissipated
within the torso increases slightly (by less than 10%).
Finally, in Figures 6E and 6F, similar data is shown to panels B & D, respectively, however, in this
particular case simulations were conducted with the entire torso (with normal conductivity), but analysis
of η was performed with the limited torso dimensions. Thus, the form of the solution (the potential and
its gradient) does not change with torso height. DFT data is not shown, as the value is constant at
55.1 J, corresponding to the same value shown in Figure 5A. In addition to a constant DFT, the energy
dissipated in the heart remains constant for all torso heights considered in the analysis (as the form of
the solution remains constant due to the fact that the full torso was used in its computation). Thus,
the only thing to change is the total energy dissipated in the torso (the denominator in Equation 6),
which monotonically increases by approximately 8%, which therefore monotonically decreases η, as seen.
Consequently, η varies very slightly as a torso height included in the post-simulation analysis changes.
3.5 Effect of Cardiomyopathies
The extent to which pathological hearts, representing different forms of cardiomyopathies (specifically
HCM and DCM) may introduce changes in DFT, electrical impedance and shock vector efficiency for
each electrode configuration was then assessed. Shock simulations were repeated in the 3 healthy models
within the cohort with their hearts morphologically altered to represent DCM and HCM conditions, as
described in the Section 2.1.2.
Despite the significant changes in wall thickness (HCM) and cavity volume/wall thinning (ƒDCM) rep-
resented by these additional models (as shown in Figure 3), little difference was generally seen in the re-
sulting DFTs for both cardiomyopathies considered. Figure 7 directly compares DFTs (left), impedances
(centre) and shock vector efficiencies (right) between HCM and the healthy equivalent model (upper
panels), along with the same for DCM (lower panels), for all electrode configurations, for each of the
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3 shows views from Meshalyzer of the 3 healthy / extended torso models (left) along with the 2
’new’ full torso models (right).
Figure 3: Finite element meshes of Small (top), Medium (middle), Large (bottom), New1 (top
right) and New2 (bottom right).
3
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0
Figure 6: Convergence of η (and DFT) for different size torso. A) Schematic representation of how differing
heights of the torso were excluded from the simulation and/or analysis; half-torso height is defined as the distance
from the mid-point in the axial direction. B-D) Variation of η, DFT and energy dissipated within the heart and
torso with half-torso height incorporated in both the simulation and analysis; E-F) Variation of η and energy
dissipated within the heart and torso with half-torso height incorporated in only the analysis, where simulation
was performed on the entire torso volume. Simulation data shown is for the TV-ICD setup in the TAVI 2 patient
model.
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Figure 7: Comparison of the effect on DFTs (left), electrical impedance (centre) and shock vector efficiency (right)
of HCM (upper row) and DCM (lower row) cardiomyopathies. For each metric the value is plotted in the diseased
case (HCM or DCM) against the corresponding value of the metric in the healthy heart case (with no adjustments
to the heart). The line of y = x is plotted to assist in highlighting differences between healthy and diseased hearts.
Data for all electrode configurations are shown for Small (red squares), Medium (blue diamonds)& Large (green
triangles) torsos.
three patients (represented by colours). The majority of points in both panels lie on the line of y = x;
however, some slight trends are seen.
Specifically, in the case of DCM, the TV-ICD setups (which can be identified as those with relatively low
DFTs from comparison with Figure 5A) tend to produce slightly higher DFTs compared to the healthy
cases (lying above the line). Likewise, TV-ICD electrical impedances are marginally lower in the DCM
patients. In the case of DFTs in HCM, there is a trend for a slight reduction in DFT in HCM patients;
this is marginally more apparent for the S-ICD configurations. Likewise, TV-ICD electrical impedances
also show a slight increase, relative to the healthy models.
Despite these marginal differences seen in DFTs and impedances between healthy and diseased hearts,
more pronounced differences are seen in shock vector efficiency. Most noticeably, for example, the TV-
ICD setups show a decrease in η in both HCM and DCM for the Small patient, whereas a small increase
is seen in the Medium patient for HCM. The Small patient data appears to be an outlier in this case;
on the whole, there seems to be a slight trend for increases in shock vector efficiency in both HCM and
DCM across all electrode configurations.
3.6 Relating η to DFTs and Impedances
The degree to which the metrics DFT, impedance and shock vector efficiency are related to one-another
is now explicitly explored by producing correlation plots. Figure 8 shows such correlation plots, which
include all simulation data for all configurations (S-ICD and TV-ICD) and all patients in the cohort
(healthy, HCM/DCM equivalent, and TAVI patients) of DFT versus impedance (panel A), DFT versus
η (panel B), and impedance versus η (panel C).
Although some outliers exist, Figure 8 A suggests that DFT and electrical impedance are approximately
correlated, as might be expected, such that a low (high) impedance corresponds to a low (high) DFT,
with a correlation coefficient of 0.855. Furthermore, Figure 8 B & C suggest that DFT and impedance
are both negatively correlated with η, such that a low (high) DFT or impedance generally corresponds
to a high (low) η, with correlation coefficients of −0.791 and −0.839, respectively. However, the plots
also highlight crowding of points along both x and y directions. For example, in panel B, for lower DFTs,
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A B C
Figure 8: Correlation plots of DFT versus impedance (panel A), DFT versus shock vector efficiency (panel B) and
impedance versus shock vector efficiency (panel C). Plots contain data for both S-ICD and TV-ICD configurations
for all five initial patients (Small, red squares; Medium, blue diamonds; Large, green triangles; TAVI1, orange
diamonds; TAVI2, magenta inverted triangles) as well as the additional cardiomyopathy variants for the Small,
Medium and Large patients.
a number of points are seen to have very similar DFT (approximately < 5 J), but have very different
values of η (approximately 6−13%); conversely, for lower values of η, a number of points are seen to have
very similar η (approximately < 1%), but have very different values of DFT (between approximately
55− 95 J). A similar situation is also seen in panel C; for lower values of impedance, a number of points
have very similar impedances values (between approximately 40− 50 Ω), but have very different values
of η (between approximately 4− 13%); conversely, for lower values of η, a number of points are seen to
have very similar η (approximately < 1%), but have very different impedances (between approximately
110− 175 Ω).
4 Discussion
In this study, we present the generation of the first cohort of whole torso-cardiac models from high-
resolution CT data, and incorporating all visible organ types from the imaging data, as well as anatomically-
based representation of the anisotropic conduction within the heart. Simulation of shocks applied via
different ICD configurations are used to demonstrate the utility of a novel shock vector efficiency metric,
which is shown to be complementary to conventional metrics such as DFT surrogate (based on ∇φe
criteria) and tissue impedance. The inclusion of a range of body sizes and compositions, along with
pathological morphological alterations to the cohort, allowed us to demonstrate the key additional infor-
mation provided by the shock vector efficiency that might help optimise electrode configuration design.
Significant differences in all quantitative metrics analysed were seen across the cohort, emphasising the
need to represent heterogeneity in patient torso and cardiac anatomy when assessing novel ICD electrode
configuration efficacy.
4.1 Use of η along with other metrics
An important part of this present study was the introduction of a novel computational metric which
allowed us to quantitatively compare the fraction of energy dissipated within the ventricular myocardium,
relative to the entire torso, for a particular electrode configuration, which we termed the shock vector
efficiency, η. In this context, the term ’vector’ was used in-line with the standard ICD device convention
[11] to describe a specific electrode anode/cathode shocking configuration (although rigorously should
be reserved for a single point anode/cathode setup.) Such a metric may have important implications
in future device design as maximising energy efficiency of an ICD (for the same DFT ) would minimise
the energy dissipated in the surrounding torso, potentially limiting extra-cardiac tissue damage and
associated problems.
DFT is an important metric for quantifying and comparing ICD configuration efficacies, but has its
limitations. For example, it does not consider current paths through other organs, only what is happening
to the heart. The correlation between DFT and impedance is also not necessarily robust; generally, a
low impedance will give a low DFT.
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For example, the impedance of the dual-coil (TV-ICD2) is lower than that of the single-coil configuration
(TV-ICD1) as the current is more ’spread-out’ in the former increasing the effective cross-sectional area
through which it flows and correspondingly decreasing the DFT slightly (Figure 5), as expected from
clinical studies [27]. Furthermore, the most obvious case of this is for electrodes which are close together,
spanning the heart; here, the impedance is low (due to a short current path-length), and correspondingly
the voltage gradient (across the heart) is high (as the majority of the voltage is dropped across the heart),
However, a low impedance is also formed if the electrodes are close to one another but do not span the
heart (as current path-length is still small), but due to the lack of field across the heart, voltage gradient
within the heart is low, and so DFT is necessarily high. This highlights the potential limitations of also
considering impedance (which is a clinically-measurable quantity) in its relation to DFT and/or shock
vector efficacy.
A strong correlation was also seen between η and DFT, which perhaps may be expected as both are driven
by high voltage gradients within the heart. However, the utility of our novel metric in determining the
efficacy of specific electrode configurations is perhaps highlighted by the cases in which this correlation is
not so strong. For example, for some values of η, it was seen that similar energy is needed to produce very
different DFTs, but also that similar DFTs can result from very different values of η. Perhaps considering
both η and DFT could be of significant utility in determining optimal ICD electrode configurations.
Evidently, the DFT is the metric that determines the actual energy utilised by the device itself. However,
a device configuration that has a high value of η, for a given DFT, would deposit more of this energy
in the myocardium, where it is needed, limiting the extra-cardiac field and associated problems. This
would seem to be an important future device design consideration.
Overall, the correlation plots of Figure 8 highlight that the specific relations between DFT, impedance
and η are complex, and depend strongly on the individual heart/torso make-up and exact nature of the
current path defined by the shock vector. This emphasises the utility of considering an additional metric,
such as η, in the optimisation of electrode configurations and shock vectors, particularly in light of the
significant variation in all metrics considered within the our heterogeneous torso model cohort.
4.2 Variation Within Cohort
In general, the specific distribution of voltage within the heart for a given shock strength and electrode
configuration (which in turn govens DFT, impedance and η) is determined by two factors: 1) the physical
separation (and location) of the electrodes defining the configuration and shock vector; and, 2) the exact
constitution of organs in a particular patient, and where they specifically lie with respect to the applied
shock vector and resulting current paths.
In smaller torsos, the reduced distance between the electrodes leads to the production of a stronger
electric field, and hence overall higher voltage gradients, meaning that lower DFTs are required. For
the majority of configurations, the Small torso had the lowest DFT, then the Medium, with the Largest
patient having the biggest DFT. Furthermore, the impedances of the configurations were seen to be
generally higher as the size of the torso increased. The slightly heterogeneous nature of the DFTs from
these patients is possibly explained by the presence of the lung, extending down in front of the heart for
TAVI 1 patient, and by a high amount of fat.
This finding further emphasises that fact that due to the heterogeneous nature of the conductivities of
the respective organ types, what lies within the current paths also is a key determinant of the shock
efficacy metrics considered. As can be seen from Table 1 and Figure 2, and the quantitative results
shown later, patients who have an overall torso with similar dimensions can have vastly different DFT, η
and impedances. This result emphasises the importance of assessing novel ICD configurations within a
cohort of individuals with a range of physical torso sizes as well as body tissue composition, as performed
in this work. Although there was similarity in overall trends and observations between individuals within
the cohort, we believe that demonstrating these similarities represents an important aspect of this work
which would not be known from a single model investigation.
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4.3 Variation With Pathology
The amount of ventricular myocardial tissue encompassed by any given shock vector is potentially impor-
tant when considering different ICD electrode configurations. The effect of different cardiomyopathies,
specifically HCM and DCM, which introduce distinctive changes in ventricular cavity dimensions and
wall thickness, were therefore considered, in the context of changes in the quantitative metrics which
relate to ICD shock efficacy of different setups. In this study, a distinct advantage was that we were
able to morphologically alter the hearts within the healthy patients in the cohort, allowing us to directly
compare the effects of HCM and DCM in hearts that were within exactly the same torso geometry, for
3 separate individuals. Similarly to previous studies [12], despite fairly significant changes in cardiac
anatomy when representing the HCM and DCM hearts (seen in Figure 3), there was no clear difference
seen in DFTs between these different pathologies. However, although not significant, a slight trend was
seen for a marginally increased DFT in the context of DCM. We believe that this is a result of the
dilated heart walls moving further away from the primary shock vector, and into regions of lower voltage
gradient, thus requiring a higher DFT. However, this trend was only seen in some of the patients and for
some of the electrode configurations tested. Indeed some of the patients showed very slight decreases in
DFT during DCM for some configurations. In the case of HCM, again, although not a significant change,
there was a slight trend noticed for a reduction in DFT in HCM patients. Such a slight reduction in HCM
patients was also noted in another recent study [12]. It should be noted, though, that here we consider
only the geometrical effects of DCM/HCM changes; we do not represent any form of electrophysiological
and tissue microstructural changes that may occur in these pathological conditions.
In addition to changes in DFT, analysing the corresponding changes in η also provided useful in these
pathological scenarios. Specifically, a slight increase in η was witnessed in both HCM and DCM, relative
to the healthy cases. In such pathological scenarios, myocardial tissue volume is increased, meaning that
the heart occupies more of the torso volume. For example, the average increase in myocardial tissue
volume was some 42% in the HCM case whilst just 2% in the DCM case. Even in the case in which
the voltage field is unchanged, this would necessarily lead to an increase in η as more energy will be
stored in the heart and less in the torso. However, it is important to realise that the electric field is
highly non-linear in its decay away from the electrodes, meaning that only adding myocardial volume
in the regions of highest electric field would have appreciable changes in η, not to mention the fact
specific voltage field distributions would also differ between pathologies. Nonetheless, we believe that η
represents an important additional metric to be considered in these cases.
4.4 Consideration of Torso Height
When performing image-based computational modelling studies aimed at quantifying electric field distri-
butions generated by different ICDs, an important consideration is the size (or height) of torso needed to
faithfully represent the specific electrode configurations under investigation. By excluding progressively
larger regions from the top/bottom of one of our models we demonstrated a significant impact on the
metrics used to quantify defibrillation efficacy. With larger volumes of torso included in the model,
current is not as confined to flow directly through the heart itself, as the pathways for the current to
flow through open up, decreasing the impedance between electrodes. This ‘spreading-out’ of the current,
means that the electric field lines also spread-out, decreasing the voltage gradient through the heart,
leading to a stronger applied field strength required to defibrillate, increasing DFT, as shown in Figure
6C.
However, in the case of η the relationship is not as clear. Here, the decrease in field strength throughout
the torso with increasing torso height means that the energy density dissipated in all organs decreases.
As the volume of the heart remains constant, the numerator in Equation 6 decreases monotonically;
however, in the denominator, the energy density in each organ decreases, but the volume represented by
the organs (more specifically, the additional organs included as the torso increases in height) increases. It
is a consequence of this that the change in η of the torso volumes considered is less than that of the DFT
(η decreases by approximately 30% between torso half-heights of 80-160 mm, compared to DFT which
increases by approximately 65% over the same range).. Thus, we conclude that shock vector efficiency
may be an important additional metric for use in comparison between different torsos within a cohort in
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a scenario in which the height or volume of the torsos may vary. It is also of relevance for guidance of
future torso-heart model construction endeavours that the shock vector efficiency somewhat converges
for torso heights of approximately > 20 cm; interestingly, although DFT is also seen to converge with
torso height, this seems to be less rapid than η e.g. between torso half-heights of 140-160 mm, η changes
by approximately 3% compared to DFT which changes by approximately 6%.
4.5 Relation with critical mass hypothesis
The use of the 95% of tissue with voltage gradient > 5 V/cm as a surrogate for DFT is widely used in both
experimental and computational modelling fields. This criteria is based on the sound theoretical reasoning
that it is the electric field strength (and its gradient) that drives the changes in membrane potential. Such
changes in Vm are key in prolonging tissue refractoriness and/or producing additional excitations, both
of which are required to eliminate excitable gaps within the majority of the myocardium to terminate
fibrillatory activity. More specifically, we note that these changes are driven by the combination of the
electric field strength weighted by the heterogeneity in tissue conductivity, along with the gradient of
the field weighted by the conductivity itself [30].
However, a recent modelling study suggested that this surrogate did not compare well to the actual shock
voltage required to defibrillate simulated episodes of VT/VF [22]; although, a more recent simulation
study suggested a closer correlation, comparing actual recorded clinical DFTs with voltage gradients
simulated in patient-specific models (although not simulating episodes of VT/VF as in [22]). In the
clinic, defibrillation is not effective 100% of the time, even when shocks may successfully achieve the
∇φe criterion i.e. achieving 95% of tissue with voltage gradient > 5 V/cm. Thorough testing of a given
configuration to reliably characterise DFT would thus require large numbers of different episodes to
be simulated, each with their own dynamics as well as shocks being applied at differing phases within
each episode, in order to achieve statistical significance. Furthermore, the successful defibrillation of a
simulated episode of VT/VF is hugely dependant upon numerous functional parameters incorporated
into the model, such as conduction velocity and ion channel kinetics, their individual restitution and
heterogeneity throughout the heart. Thus, the use of more simple metrics, such as directly computing
the response of the tissue to the shock via the ∇φe criterion, would seem a practical way of directly
comparing shock efficacy of different ICD configurations i.e. the direct effect of the particular shock
vector on the heart. Moreover, the use of metrics such as the shock vector efficiency presented here have
the further advantage of providing additional information which may be used to compare different shock
vectors.
4.6 Study Limitations
The specific values of conductivities used for the various organ types having widely differing values
reported in the literature. Variation in these values impacts the potential distribution within the heart-
torso and thus quantitatively affects the metrics computed in this work (DFT, impedance, η). Due to
this significant variation, we considered our quantitative results in the context of a single set of con-
ductivity values, as used in a recent S-ICD modelling study [12]. We acknowledge that are simulations
were performed using a simple Laplace solve and direct computation of the DFT via the ‖∇φe‖ criteria,
as described, and that we did not perform full bidomain simulations of the biphasic shock nor corre-
sponding computations of the exact energy used by the device. Nonetheless, due to similarities seen in
φe distributions using Laplace solves and monophasic bidomain shocks (as described in Section 2.4), we
believe that our results provide a useful means of directly comparing different metrics related to ICD
electrode configurations in individuals.
5 Conclusions
The shock vector efficiency represents a useful additional metric to be considered in the optimisation of
ICD electrode configurations. It may provide particularly useful information in the context of differing
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torso anatomies and cardiac pathologies, which can lead to significant heterogeneity in conventional
metrics such as DFT and impedance. This heterogeneity between subjects also emphasises the need
to conduct such simulation and practical investigations in the context of a cohort of detailed whole
torso-cardiac models.
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